Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Can exercise help older sickle cell patients? new study says maybe

NCT ID NCT05714098

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 33 times

Summary

This study tested a personalized exercise program called Gerofit for 30 older adults with sickle cell disease. The program included cardiovascular, strength, and balance training, plus mindfulness, all done remotely. The goal was to see if it was safe, doable, and helpful for improving physical health and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Duke University

    Durham, North Carolina, 27710, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Gerofit Exercise Program

What this could lead to

If successful, this could show that a tailored exercise program is safe and helpful for older adults with sickle cell disease, potentially improving their daily function and well-being.

What could go wrong

This was a small, early feasibility study with only 30 participants, so results may not apply to everyone. Exercise might cause pain or fatigue in some individuals.

Conditions

The condition(s) this trial relates to.

Motor Activity sickle cell disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.